List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 26 studies with search of: "Deoxyglucose"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting A Phase I/II Trial of 2-Deoxyglucose (2DG) for the Treatment of Advanced Cancer and Hormone Refractory Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: 2-deoxyglucose
2 Active, not recruiting Safety Study of 2DG With Stereotactic Radiosurgery
Conditions: Intracranial Neoplasms;   Neoplasm Metastasis
Intervention: Drug: 2-deoxyglucose (2DG)
3 Completed Dose Escalation Trial of 2-Deoxy-D-Glucose (2DG) in Subjects With Advanced Solid Tumors
Conditions: Lung Cancer;   Breast Cancer;   Pancreatic Cancer;   Head and Neck Cancer;   Gastric Cancer
Intervention: Drug: 2-deoxy-D-glucose (2DG)
4 Recruiting Pharmacokinetic and Radiation Dosimetry Study Evaluating 99m TC-EC-DG SPECT/CT in Patients With Non-Small Cell Lung Cancer (NSCLC)
Condition: Non Small Cell Lung Cancer
Interventions: Radiation: Radiolabeled (99Tc) EC-DG (ethylenedicysteine-deoxyglucose);   Radiation: Technetium 99m ethylenedicysteine-deoxyglucose;   Radiation: 18 F fluorodeoxyglucose
5 Recruiting Phase 2 Study Comparing 99mTc-EC-DG SPECT/CT With 18F FDG PET/CT in Patients With Non-Small Cell Lung Cancer (NSCLC)
Condition: Non Small Cell Lung Cancer
Interventions: Radiation: Radiolabeled (99Tc) EC-DG (ethylenedicysteine-deoxyglucose);   Radiation: 18 F flourodeoxyglucose
6 Completed Phase II Study of the Role of Anti-CEA Antibody Immunoscintigraphy & Positron Emission Tomography in the Localization of Recurrent Colorectal Carcinoma in Patients With Rising Serum CEA Levels in the Absence of Imageable Disease by Conventional Modalities
Condition: Colorectal Neoplasm
Intervention: Drug: 2-Fluoro-2-deoxyglucose
7 Active, not recruiting Remission Evaluation Before Intensified Treatment in Lymphoma: Impact of Positron Emission Tomography (PET) Using Fluorine-18-Floro-Deoxyglucose (FDG) in the Therapeutic Prescription. Medico-Economic Randomised Study
Condition: Lymphoma
Intervention: Procedure: positron emission tomography
8 Recruiting Predictive Value of FDG-PET-CT Scans for Patients With Lung Cancer Receiving Concurrent Chemo-Radiation
Conditions: Lung Cancer;   SCLC;   NSCLC
Intervention: Other: 18F-deoxyglucose (FDG)
9 Recruiting Assessment of Treatment Response Using PET/CT Scanner - Non Hodgkin's Lymphoma
Condition: Lymphoma, Non-Hodgkin
Intervention: Procedure: PET Scan with [18F]Fluoro-2-deoxyglucose (FDG)
10 Recruiting [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
Condition: Prostate Cancer
Intervention: Other: PET scan
11 Not yet recruiting Radiotherapy Planning Based on Positron Emission Tomography With Fluoro-Deoxyglucose For Advanced NSCLC
Condition: Non-Small Cell Lung Cancer
Intervention: Procedure: restriction of radiotherapy to FDG-PET positive areas only
12 Recruiting The Utility and Cost-Effectiveness Analysis of 18F-FDG PETin Staging Potential Operable Non-Small Cell Lung Cancer
Condition: Non Small Cell Lung Cancer
Intervention:
13 Recruiting A Study To Investigate The Ability To Use 18FDG PET Scanning To Monitor The Effectiveness Of New Drugs In COPD Patients
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Procedure: PET imaging
14 Recruiting Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer
Conditions: Brain Neoplasms;   Lung Neoplasms;   Thyroid Neoplasms;   Colorectal Neoplasms;   Lymphoma
Intervention: Procedure: Positron Emission Tomography (PET) scan
15 Recruiting Study of F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Cancers of Low Incidence
Conditions: Sarcoma;   Multiple Myeloma;   Testicular Neoplasms;   Ovarian Neoplasms;   Kidney Neoplasms
Intervention: Procedure: Positron Emission Tomography
16 Active, not recruiting Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Soft Tissue Sarcoma
Condition: Sarcoma
Intervention: Procedure: Positron Emission Tomography
17 Terminated Study of Fluorodeoxyglucose (FluGlucoScan) in Patients With Breast Cancer: Correlation With Histologic Findings of Sentinel Node Biopsies and Axillary Dissection
Condition: Breast Neoplasms
Intervention: Procedure: Positron Emission Tomography Imaging
18 Recruiting 18F-Fluorodeoxyglucose (18F-FDG) Positron Emission Tomography in Oncology
Conditions: Brain Neoplasms;   Lung Neoplasms;   Lymphoma;   Melanoma;   Colorectal Neoplasms
Intervention: Procedure: Positron Emission Tomography
19 Recruiting Study of Temsirolimus, Topotecan, and Bortezomib
Condition: Advanced Cancer
Interventions: Drug: Torisel (Temsirolimus);   Drug: Hycamtin (Topotecan);   Drug: Velcade (Bortezomib)
20 Active, not recruiting PET Scan in Treating Patients With Metastatic Prostate Cancer
Condition: Prostate Cancer
Interventions: Procedure: positron emission tomography;   Radiation: fludeoxyglucose F 18;   Radiation: methionine C 11

Previous Page Studies Shown (1-20) Next Page (21-26)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services